Retatrutide Shows Promise in Reducing Sleep Apnea in Trials | Retatrutide News

Retatrutide, a triple-action weight-loss drug, reduced sleep apnea in two late-stage trials. This finding highlights its potential benefits beyond weigh...
Clinical Trials · October 24, 2026